Cargando…
Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
BACKGROUND: Macrolide antibiotics such as erythromycin and roxithromycin (RXM) have an anti-inflammatory effect that may account for their clinical benefit in the treatment of chronic airway inflammatory diseases. However, the precise mechanism of this anti-inflammatory effect is not well understood...
Autores principales: | Kanai, Ken-Ichi, Asano, Kazuhito, Hisamitsu, Tadashi, Suzaki, Harumi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781582/ https://www.ncbi.nlm.nih.gov/pubmed/15770046 http://dx.doi.org/10.1155/S0962935104000468 |
Ejemplares similares
-
Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
por: Suzuki, Mayumi, et al.
Publicado: (2002) -
Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.
por: Suzaki, H, et al.
Publicado: (1999) -
Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice.
por: Terao, Hajime, et al.
Publicado: (2003) -
Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
por: Shimane, T, et al.
Publicado: (2001) -
Suppression of Matrix Metalloproteinase Production in Nasal
Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
por: Shimizu, Toshiyuki, et al.
Publicado: (2005)